Literature DB >> 2592016

Antibodies to a short synthetic peptide related to the hinge segment of human IgG3 recognizes thermally or fixative induced conformational changes in the human IgG3 molecule.

W J Boersma1, C Deen, J J Haaijman, J Radl, E Claassen.   

Abstract

A synthetic decapeptide (SP) was used to produce a murine monoclonal antibody specific for the human IgG3 molecule. Recognition of the IgG3 determinant is heat- and fixation-sensitive in ELISA and immunoenzyme cytology, respectively. The antibody specifically recognizes a sequence from the hinge region of IgG3, but only when subtle alterations in the conformation are induced by mild heating (greater than 40 degrees) and subsequent stabilization by means of electrostatic interactions in solid-phase assays or by fixation with formalin acetic acid mercury chloride. The structure of the human IgG3 molecule is especially sensitive to microenvironmental influences, as can be concluded from its behaviour under various physicochemical conditions. To this, we add that the immunogenic determinants in the structure of relatively flexible parts of this protein can be severely altered by the routine application of fixation methods. It is shown that these changes can also be of importance in the recognition of antigen by monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592016      PMCID: PMC1385459     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  7 in total

1.  Immunogenic and antigenic epitopes of immunoglobulin--XX. Denaturation of human IgG3 by free radicals.

Authors:  S A Jose; H Griffiths; J Lunec; R A Mageed; R Jefferis
Journal:  Mol Immunol       Date:  1987-11       Impact factor: 4.407

2.  A monoclonal antibody raised against a synthetic peptide representative of part of the amino acid sequence of rat immunoglobulin E detects thermally induced changes in that region of the IgE molecule.

Authors:  G Z Hastings; D S Burt; D R Stanworth
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

3.  IgG subclass distribution in juvenile human tonsil: IgG3 and IgG4 results of specific antibody production using synthetic peptides.

Authors:  W J Boersma; C Deen; N D Zegers; J Radl; J J Haaijman
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

4.  Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  P Brandtzaeg; L Surjan; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

5.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

Authors:  R Jefferis; C B Reimer; F Skvaril; G de Lange; N R Ling; J Lowe; M R Walker; D J Phillips; C H Aloisio; T W Wells
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

6.  Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit.

Authors:  T E Michaelsen; B Frangione; E C Franklin
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

7.  Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia.

Authors:  J van Denderen; A Hermans; T Meeuwsen; C Troelstra; N Zegers; W Boersma; G Grosveld; W van Ewijk
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

  7 in total
  2 in total

1.  Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils.

Authors:  S Hoefakker; E H van 't Erve; C Deen; A J van den Eertwegh; W J Boersma; W R Notten; E Claassen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

2.  Fixation of cryo-sections under HIV-1 inactivating conditions: integrity of antigen binding sites and cell surface antigens.

Authors:  J D Laman; N Kors; J L Heeney; W J Boersma; E Claassen
Journal:  Histochemistry       Date:  1991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.